These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 10658624)

  • 41. A serotonergic (5-HT2) receptor mechanism in the laterodorsal tegmental nucleus participates in regulating the pattern of rapid-eye-movement sleep occurrence in the rat.
    Amici R; Sanford LD; Kearney K; McInerney B; Ross RJ; Horner RL; Morrison AR
    Brain Res; 2004 Jan; 996(1):9-18. PubMed ID: 14670626
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Insomnia Caused by Serotonin Depletion is Due to Hypothermia.
    Murray NM; Buchanan GF; Richerson GB
    Sleep; 2015 Dec; 38(12):1985-93. PubMed ID: 26194567
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increases in avoidance responding produced by REM sleep deprivation or serotonin depletion are reversed by administration of 5-hydroxytryptophan.
    Smith RL; Kennedy CH
    Behav Brain Res; 2003 Mar; 140(1-2):81-6. PubMed ID: 12644281
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Citalopram: differential sleep/wake and EEG power spectrum effects after single dose and chronic administration.
    Neckelmann D; Bjorvatn B; Bjørkum AA; Ursin R
    Behav Brain Res; 1996 Sep; 79(1-2):183-92. PubMed ID: 8883829
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of serotonin 5-HT7 receptor in regulating sleep and wakefulness.
    Monti JM; Jantos H
    Rev Neurosci; 2014; 25(3):429-37. PubMed ID: 24681431
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intraperitoneal injection of cholecystokinin elicits sleep in rabbits.
    Kapás L; Obál F; Opp MR; Johannsen L; Krueger JM
    Physiol Behav; 1991 Dec; 50(6):1241-4. PubMed ID: 1798781
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents.
    Bonaventure P; Kelly L; Aluisio L; Shelton J; Lord B; Galici R; Miller K; Atack J; Lovenberg TW; Dugovic C
    J Pharmacol Exp Ther; 2007 May; 321(2):690-8. PubMed ID: 17314195
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Kindling stimuli delivered at different times in the sleep-wake cycle.
    Yi PL; Tsai CH; Lin JG; Lee CC; Chang FC
    Sleep; 2004 Mar; 27(2):203-12. PubMed ID: 15124712
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interleukin-8 promotes non-rapid eye movement sleep in rabbits and rats.
    García-García F; Yoshida H; Krueger JM
    J Sleep Res; 2004 Mar; 13(1):55-61. PubMed ID: 14996036
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship between extracellular 5-hydroxytryptamine and behaviour following monoamine oxidase inhibition and L-tryptophan.
    Sleight AJ; Marsden CA; Martin KF; Palfreyman MG
    Br J Pharmacol; 1988 Feb; 93(2):303-10. PubMed ID: 2451963
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adenosine A1 receptor agonist GR79236 suppresses apnea during all sleep stages in the rat.
    Carley DW; Hagan RM; Sheehan M; Trbovic S; Thai T; Radulovacki M
    Sleep; 1997 Dec; 20(12):1093-8. PubMed ID: 9493917
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Microdialysis perfusion of 5-HT into hypoglossal motor nucleus differentially modulates genioglossus activity across natural sleep-wake states in rats.
    Jelev A; Sood S; Liu H; Nolan P; Horner RL
    J Physiol; 2001 Apr; 532(Pt 2):467-81. PubMed ID: 11306665
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 2, pharmacological interactions in rodents suggest a role of serotonin-3 receptor antagonism.
    Leiser SC; Iglesias-Bregna D; Westrich L; Pehrson AL; Sanchez C
    J Psychopharmacol; 2015 Oct; 29(10):1092-105. PubMed ID: 26174134
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Soluble tumor necrosis factor receptor (p75) does not attenuate the sleep changes induced by lipopolysaccharide in the rat during the dark period.
    Lancel M; Mathias S; Schiffelholz T; Behl C; Holsboer F
    Brain Res; 1997 Oct; 770(1-2):184-91. PubMed ID: 9372218
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The selective group mGlu2/3 receptor agonist LY379268 suppresses REM sleep and fast EEG in the rat.
    Feinberg I; Campbell IG; Schoepp DD; Anderson K
    Pharmacol Biochem Behav; 2002 Sep; 73(2):467-74. PubMed ID: 12117602
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The regulation of 5-hydroxytryptamine release from superfused synaptosomes by 5-hydroxytryptamine and its immediate precursors.
    Suter HA; Collard KJ
    Neurochem Res; 1983 Jun; 8(6):723-30. PubMed ID: 6604881
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dose-related suppression of REM sleep and PGO waves by the serotonin-1 agonist eltoprazine.
    Quattrochi JJ; Mamelak AN; Binder D; Williams J; Hobson JA
    Neuropsychopharmacology; 1993 Jan; 8(1):7-13. PubMed ID: 8424848
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Compensatory sleep responses to wakefulness induced by the dopamine autoreceptor antagonist (-)DS121.
    Olive MF; Seidel WF; Edgar DM
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1073-83. PubMed ID: 9618410
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tumor necrosis factor-beta induces sleep, fever, and anorexia.
    Kapás L; Krueger JM
    Am J Physiol; 1992 Sep; 263(3 Pt 2):R703-7. PubMed ID: 1415661
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endogenous melatonin is not obligatory for the regulation of the rat sleep-wake cycle.
    Fisher SP; Sugden D
    Sleep; 2010 Jun; 33(6):833-40. PubMed ID: 20550025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.